PSMD10 and hepatocellular carcinoma: Several studies have demonstrated effect of Gankyrin on oncogenic potential in hepatocellular carcinoma cells due to increased cell proliferation and malignant transformation of normal hepatocytes [20, 23, 24, 49, 50].